Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Minoxidil effectively treats female pattern hair loss.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Finasteride may help some women with hair loss, but better options exist.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.